In the present study we aimed to explore not only the NK maturation subpopulations and their expression of the four selected inhibitory receptors (3 iKIRs and NKG2A) in AML patients, but also to place these data in the context of the KIR genotypes and HLA-C profiles. Here, KIR3DL1 is linked to acute myeloid leukemia.